Sichenzia Ross Ference LLP Represents Equillium, Inc. in a $30 Million Registered Direct Offering By Sichenzia Ross Ference LLP | February 8, 2021 Equillium, Inc. $30,000,000 Common Stock and Warrants February 2021 Read More
Sichenzia Ross Ference LLP Represents Aegis Capital in $12.1 Million Follow-On Offering of BiondVax Pharmaceuticals Ltd. American Depositary Shares By Sichenzia Ross Ference LLP | February 3, 2021 BiondVax Pharmaceuticals Ltd. $12,100,000 American Depository Shares February 2021 Read More
Sichenzia Ross Ference LLP Represents High Tide Inc. in the $8.0 million acquisition of Smoke Cartel, Inc. By Sichenzia Ross Ference LLP | January 25, 2021 High Tide Inc. $8,000,000 Acquisition January 2021 Read More
Sichenzia Ross Ference LLP Represents Lexaria Bioscience Corp. in Close of $11 Million Underwritten Public Offering and NASDAQ Uplisting By Sichenzia Ross Ference LLP | January 15, 2021 Lexaria Bioscience Corp. $11,000,000 Common Stock and Warrants January 2021 Read More
Sichenzia Ross Ference LLP Represents Vuzix in $15.5 Million Registered Direct Offering By Sichenzia Ross Ference LLP | September 10, 2020 Vuzix Corporation $15,000,000 Common Stock September 2020 Read More
Sichenzia Ross Ference LLP Represents Aegis Capital as Sole Bookrunner in $5.2 Million Underwritten Public Offering of Avinger Inc. Common Stock By Sichenzia Ross Ference LLP | August 26, 2020 Avinger, Inc. $5,200,000 Common Stock August 2020 Read More
Sichenzia Ross Ference LLP Represents Aegis Capital in $5.4 Million Public Offering of Avinger, Inc. Common Stock By Sichenzia Ross Ference LLP | June 26, 2020 Avinger, Inc. $5,400,000 Common Stock June 2020 Read More
Sichenzia Ross Ference LLP Represents Lexaria Bioscience Corp. in $2 Million Private Placement By Sichenzia Ross Ference LLP | May 10, 2020 Lexaria Bioscience Corp. $2,000,000 Common Stock and Warrants May 2020 Read More
Sichenzia Ross Ference LLP Represents Beyond Air in $50 Million At-The-Market Offering By Sichenzia Ross Ference LLP | May 9, 2020 Beyond Air, Inc. $50,000,000 At-The-Market Offering April 2020 Read More
Sichenzia Ross Ference LLP Represents Aegis Capital in $5.5 Million Follow-On Offering of CEL-SCI Corporation Common Stock By Sichenzia Ross Ference LLP | May 8, 2020 CEL-SCI Corporation $5,500,000 Common Stock December 2019 Read More